ProCE Banner Activity

Managing AEs With CDK4/6 Inhibitors to Promote Adherence and Persistence to Oral Therapy in Your Practice

Slideset

Download these slides covering the latest evidence and recommendations on how to mitigate AEs secondary to CDK4/6 inhibitors and promote adherence and persistence with treatment.

Released: December 06, 2024

Expiration: December 05, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation